Description
An ABHD12 inhibitor (IC50 = 11 nM); inhibits ABHD-dependent hydrolysis of lyso-PS in mouse brain membrane lysates (IC50 = 2.8 nM) and human THP-1 cells; increases levels of CCL3, CCL4, TNF-α, and IL-1β in M1-polarized THP-1 macrophages; increases levels of 1-stearoyl-2-hydroxy-sn-glycero-3-PS, 1-arachidonoyl-2-hydroxy-sn-glycero-3-PS, 1-docosanoyl-2-hydroxy-sn-glycero-3-PS, 1-stearoyl-2-arachidonoyl-sn-glycero-3-PS, and 1-oleoyl-2-arachidonoyl-sn-glycero-3-PS in mouse brain at 30 mg/kg per day for four weeks; increases levels of CCL2, CCL3, and CCL5 in BALF and decreases survival in a mouse model of infection with LCMV clone 13 at 30 mg/kg
Formal name: N-[1-[3-chloro-4-[2-chloro-4-(trifluoromethoxy)phenoxy]-2-pyridinyl]-4-piperidinyl]-N′-3-pyridinyl-thiourea
Synonyms:
Molecular weight: 558.4
CAS: 2301866-59-9
Purity: ≥98%
Formulation: A solid